New Key Statistics Module, Z-Score and F-Score
AMEX:ZOM Key Ratios
| Market Cap $ M | 143.96 |
| Enterprise Value $ M | 60.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.70 |
| Price/Sales | 5.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 26.00 |
| EPS (TTM) $ | -0.07 |
| Beneish M-Score | -2.95 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 38.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.98 |
| EV-to-EBITDA | -1.12 |
| PEG | -- |
| Shares Outstanding M | 979.95 |
| Net Margin (%) | -232.70 |
| Operating Margin % | -143.14 |
| Pre-tax Margin (%) | -232.24 |
| Quick Ratio | 10.15 |
| Current Ratio | 10.82 |
| ROA % (ttm) | -25.79 |
| ROE % (ttm) | -27.17 |
| ROIC % (ttm) | -25.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.44 |
ZOM Number of Guru Trades
ZOM Volume of Guru Trades
Gurus Latest Trades with AMEX:ZOM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ZOM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zomedica Corp Insider Transactions
No Available Data
News about AMEX:ZOM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers